What they were paid
National Health Investors Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $202,500 | $0 | $88,380 | $0 | $290,880 |
| FY2023 | $120,000 | $0 | $70,860 | $0 | $190,860 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: National Health Investors Inc. DEF 14A filed April 3, 2026, accession 0000877860-26-000098, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025National Health Investors pays directors a $75,000 cash retainer and $88,380 in equity.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance · Special Committee
The rest of the National Health Investors board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Candice W. Todd | Independent Director | $240,880 |
| D. Eric Mendelsohn | Director | $0 |
| James R. Jobe | Independent Director | $225,880 |
| Lilly H. Donohue | Independent Director | $0 |
| Robert G. Adams | Independent Director | $205,880 |
| Robert W. Chapin, Jr | Independent Director | $176,360 |
| Tracy M.J. Colden | Independent Director | $225,880 |
The full National Health Investors compensation record
free company briefThis page is one director within National Health Investors's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat